目的探讨乙型肝炎（下称乙肝）病毒DNA（HBV-DNA）与血清免疫标志物的关系。
Objective To explore the relationship between HBV-DNA and HBV immune markers in serum.
治疗前后分别检测血清肝功能乙肝标志物、HBVDNA，并记录治疗期间发生的不良反应。
HBV DNA and HBV marker in serum were tested before and after the treatment. And all the side-effects were recorded during the period.
目的探讨放射免疫法检测各类乙型肝炎血清乙肝病毒标志物的临床意义。
Objective To evaluate the clinical significance of the radio-immunoassay method in examining various markers of Hepatitis B serum(HBV-M).
方法对住院分娩新生儿及非肝病儿童随机抽查1995例血清乙肝病毒标志物（HBVM）和抗-HCV。
Method This was an investigation at random of 1995 newborns born in our hospital and children without liver disease, the HBVM and anti HCV in their serum were detected.
方法：采用ELISA方法检测被检者乙肝血清学标志物。
Methods The five serological markers were measured by ELISA.
方法用酶联免疫吸附试验对982例乙肝患者血清标志物和乙肝病毒前S2抗原进行检测；并用荧光定量PCR法对其进行HBV-DNA检测。
Methods Hepatitis B serum markers and Pre-S2 antigens were tested by enzyme-linked immunosorbent assay and HBV DNA was detected by fluorescent quantitative-PCR in 982 hepatitis B patients.
方法采用实时荧光定量pcr、ELISA及速率法分别检测60例乙肝患者经拉米呋啶治疗后其血清YMDD、HBVDNA、乙肝标志物及alt的变化情况。
Methods the serum YMDD mutation, HBV DNA, ALT and HbeAg levels of 60 patients on lamivudine therapy were detected by FQ-PCR, ELISA, and rate method, respectively.
用快速法检测定值标本和病人血清中的乙肝标志物与常规法比较，无统计学差异，故本增速剂在乙肝酶标诊断中是可以应用的。
Hepatitis B Viral labeles in valued samples and patients sera were detected by the rapid method and the general method comparatively, the result shows that there are no statistics differences.
方法：采用血清乙肝病毒标志物阳性肾小球肾炎患者的临床与病理活检资料及实验室相关检查作对照分析。
Methods:The clinical data, laboratory results and pathological findings of renal biopsies in 40 patients with serum HBV positive glomerulonephritis were analyzed.
目的：通过药物抑制乙肝病毒血清标志物(HBV - M)的实验，观察药物抑制HBV的作用。
Objective: To investigate the effect of anti-HBV drugs using the experiment of anti-HBV-M.
目的：通过药物抑制乙肝病毒血清标志物(HBV - M)的实验，观察药物抑制HBV的作用。
Objective: To investigate the effect of anti-HBV drugs using the experiment of anti-HBV-M.
应用推荐